Management Practices for Methicillin-Resistant Bacteremia by Adult Infectious Diseases Physicians.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Author
Banniettis, NatalieBeekmann, Susan E
Polgreen, Philip M
Kaushik, Shubhi
Kohlhoff, Stephan
Gilbert, David
Bennett, John E
Hammerschlag, Margaret R
Journal title
Open forum infectious diseasesDate Published
2018-05-19Publication Volume
5Publication Issue
5Publication Begin page
ofy093
Metadata
Show full item recordAbstract
To assess current use of vancomycin for methicillin-resistant bacteremia, we surveyed adult infectious disease physicians. Most respondents reported personal experience with infections failing to respond to vancomycin despite minimum inhibitory concentration data indicating susceptibility. In a hypothetical case of such an infection, most would change to daptomycin with or without other agents.Citation
Banniettis N, Beekmann SE, Polgreen PM, Kaushik S, Kohlhoff S, Gilbert D, Bennett JE, Hammerschlag MR. Management Practices for Methicillin-Resistant Staphylococcus aureus Bacteremia by Adult Infectious Diseases Physicians. Open Forum Infect Dis. 2018 May 19;5(5):ofy093. doi: 10.1093/ofid/ofy093. PMID: 29876367; PMCID: PMC5961149.DOI
10.1093/ofid/ofy093ae974a485f413a2113503eed53cd6c53
10.1093/ofid/ofy093
Scopus Count
Collections
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International